Non-Opioid Directive Act

H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions H.R. 1218, Data Mapping to Save Moms Lives Act, all provisions S. 198, Data Mapping to Save Moms' Lives Act, all provisions H.R. 4387, Maternal Health Quality Improvement Act of 2021, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions S. 610, Dr. Lorna Breen Health Care Provider Protection Act, all provisions H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions S. 54, Strengthening Americas Health Care Readiness Act, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions H.R. 6000, Cures 2.0 Act, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, all provisions S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions S. 2866, Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act, all provisions H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to waste, fraud, and abuse in telehealth S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to waste, fraud, and abuse and telehealth H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions H.R. 1306, National Coronavirus Commission Act of 2021, all provisions S. 412, National Coronavirus Commission Act of 2021, all provisions H.R. 1843, COVID-19 Hate Crimes Act, all provisions S.937, COVID-19 Hate Crimes Act, all provisions H.R. 6279, Opioid Treatment Access Act of 2022, all provisions H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions S. 1976, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions H.R. 6904, Patients Before Profits Act of 2022, all provisions H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions S. 3039, Social Determinants Accelerator Act of 2021, all provisions H.R. 6072, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions S. 509, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions H.R. 5224, Preventing Overdoses and Saving Lives Act of 2021, all provisions H.R. 925, Data to Save Moms Act, all provisions H.R. 3352, Midwives for MOMS Act of 2021, all provisions H.R. 847, Promoting Digital Privacy Technologies Act, all provisions S. 224, Promoting Digital Privacy Technologies Act, all provisions H.R. 4098, Non-Opioid Directive Act, all provisions S. 3620, Health Data Use and Privacy Commission Act, all provisions Emergency Room Hero and Patient Safety Act Primary Care Physician Reentry Act 21st Century Cures Act/implementation Affordable Care Act (ACA)/Stabilization Ryan Haight Act/telemedicine/controlled substances No Surprises Act/implementation Physician workforce issues Opioid overdose epidemic Medical device user fee reauthorization Telehealth study COVID-19/vaccine distribution/vaccine in physician offices COVID-19/health equity/vaccine COVID-19/testing/personal protective equipment(PPE)/misinformation Pandemic preparedness and public health Health insurance affordability Mental health parity Prior authorization Health equity and technology/biometric technologies Health Equity COVID-19/Provider Relief Fund Modifier 25/OIG Information blocking/Patient privacy Naloxone/over the counter (OTC) EHR Certification Precision medicine/diagnostics/coverage/payment/coding Digital health/AI/Digital therapeutics/transparency/equity

Client expense: $6,520,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, White House Office

Issues related to Medicare policies on continuous glucose monitors and closed loop systems. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. Issues pertaining to FY22 Inpatient Rule and LITT DRG reassignment. Issue related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to non-opioid pain therapies, including H.R. 3259/S. 586 (NOPAIN Act) and H.R. 4098/S. 1292 (Non-Opioid Directive Act). Issues related to Medicare coverage of digital health technologies. Issues pertaining to Medicare provider payment cuts. Issue related to H.R. 5376, Build Back Better Act.

Client expense: $800,000 · Firm income: Not reported

Issues related to Medicare policies on continuous glucose monitors and closed loop systems. Issues related to opioid-induced respiratory compromise continuous patient monitoring. Issues pertaining to FY22 Inpatient Rule and LITT DRG reassignment. Issue related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring. Issues related to Medicare prior authorization policies. Issues related to the coverage and payment of preventative screenings. Issues related to non-opioid pain therapies, including H.R. 3259/S. 586 (NOPAIN Act) and H.R. 4098/S. 1292 (Non-Opioid Directive Act). Issues related to Medicare coverage of digital health technologies. Issue related to The Build Back Better Act, A bill to provide for Reconciliation pursuant to title II of the concurrent Resolution on the Budget for Fiscal Year 2022 S. Con Res. 14.

Client expense: $2,267,000 · Firm income: Not reported

Issues related to Medicare policies on continuous glucose monitors and closed loop systems. Issues related to value-based healthcare and modernization of fraud and abuse laws. Issue related to Medicare coverage and payment for Breakthrough-designated medical devices. Issues related to telemedicine and remote patient monitoring. Issues related to Medicare prior authorization policies. Issues related to the coverage and payment of preventative screenings. Issues related to non-opioid pain therapies, including H.R. 3259/S. 586 (NOPAIN Act) and H.R. 4098/S. 1292 (Non-Opioid Directive Act). Issues related to Medicare coverage of digital health technologies.

Client expense: $1,096,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office